Sep 29, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Bio-Techne Stock Climbs on Advances in Spatial Biology Solutions
TECH shares rise as advances in RNAscope and COMET spotlight new roles in lymphoid malignancy diagnostics.
Sep 15, 2025 • Benzinga
NEUTRAL
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne - MDxHealth ( NASDAQ:MDXH )
IRVINE, CA, and HERSTAL, BELGIUM - September 15, 2025 ( GlobeNewswire ) - MDxHealth SA MDXH ( the "Company" or "mdxhealth" ) , a leading precision diagnostics company, today announced the closing of the ExoDx business acquisition from Bio-Techne Corporation, which includes the ExoDx Prostate ...
Sep 15, 2025 • GlobeNewswire
NEUTRAL
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from ...
Sep 03, 2025 • Benzinga
SOMEWHAT-BULLISH
Bio-Techne Stock Upgraded As Analyst Flags Attractive Entry Point - Bio-Techne ( NASDAQ:TECH )
RBC Capital upgraded Bio-Techne to Outperform and lifted its price target from $61 to $73. Bio-Techne shares are down 26% over the past year and 25% year-to-date. Get Discounted Real-Time Trade Alerts For a Volatile Market ( Labor Day Special )
Aug 28, 2025 • Benzinga
SOMEWHAT-BULLISH
Director At Bio-Techne Exercises Options Worth $586K - Bio-Techne ( NASDAQ:TECH )
A large exercise of company stock options by Robert V Baumgartner, Director at Bio-Techne TECH was disclosed in a new SEC filing on August 27, as part of an insider exercise. What Happened: A notable Form 4 filing on Wednesday with the U.S.
Aug 06, 2025 • Motley Fool
NEUTRAL
Bio-Techne ( TECH ) Q4 EPS Rises 8.2%
Bio-Techne ( NASDAQ:TECH ) , a leading provider of life sciences tools and diagnostic solutions, reported its earnings for the fourth quarter of fiscal 2025 on August 6, 2025. The company's headline news was a modest beat on both revenue and non-GAAP earnings per share, with GAAP revenue of ...